Raymond James on Liquidia (LQDA): 'we see this narrower repackaging of the '793 patent as posing a relatively low risk of becoming a basis for RTO or injunction of the Yutrepia launch'
Tweet Send to a Friend
Raymond James analyst Ryan Deschner reiterated a Strong Buy rating and $29.00 price target on Liquidia Technologies (NASDAQ: LQDA)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
